Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.807 USD | 0.00% | +4.67% | +41.58% |
May. 14 | Viracta Therapeutics Appoints Michael Faerm CFO | MT |
May. 14 | Viracta Therapeutics, Inc. Appoints Michael Faerm as Chief Financial Officer | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.58% | 31.69M | |
+41.79% | 54.04B | |
+47.19% | 41.96B | |
-0.56% | 41.92B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+29.60% | 12.28B | |
+24.91% | 12.19B |
- Stock Market
- Equities
- VIRX Stock
- News Viracta Therapeutics, Inc.
- Transcript : Viracta Therapeutics, Inc. - Special Call